BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3933897)

  • 1. Spontaneous lymphocyte activity in rheumatoid arthritis in a longitudinal study in relation to gold therapy.
    Froebel KS; Lewis D; Dickson R; Sturrock RD
    Clin Rheumatol; 1985 Sep; 4(3):301-7. PubMed ID: 3933897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
    Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
    Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of immune response during chrysotherapy. Comparison of gold sodium thiomalate vs. auranofin.
    Lorber A; Jackson WH; Simon TM
    Scand J Rheumatol; 1981; 10(2):129-37. PubMed ID: 6787702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
    Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO
    Am J Med; 1983 Dec; 75(6A):133-7. PubMed ID: 6419595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate.
    Dahl SL; Coleman ML; Williams HJ; Altz-Smith M; Kay DR; Paulus HE; Weinstein A; Kaplan S
    Arthritis Rheum; 1985 Nov; 28(11):1211-8. PubMed ID: 3933523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open comparative study of auranofin vs. gold sodium thiomalate.
    Smith PR; Brown GM; Meyers OL
    J Rheumatol Suppl; 1982; 8():190-6. PubMed ID: 6813484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.
    Williams HJ; Ward JR; Egger MJ; Reading JC; Samuelson CO; Altz-Smith M; Willkens RW; Solsky MA; Hayes SP; Furst D
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():39-50. PubMed ID: 6432412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis.
    Gofton JP; O'Brien WM
    J Rheumatol Suppl; 1982; 8():169-72. PubMed ID: 6813480
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral and parenteral gold therapy and placebo in the treatment of rheumatoid arthritis.
    Williams HJ; Ward JR
    Scand J Rheumatol Suppl; 1983; 51():92-9. PubMed ID: 6426054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled comparison of oral gold with injectable gold in early rheumatoid arthritis.
    Davies J; Bacon PA; Hall ND; Ring EF
    Clin Rheumatol; 1984 Dec; 3(4):553-4. PubMed ID: 6441670
    [No Abstract]   [Full Text] [Related]  

  • 14. Gold concentrations and toxicity during oral gold treatment with auranofin.
    Sharma RP; Smillie J; Palmer DG
    Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.
    Coughlan RJ; Richter MB; Panayi GS
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():25-32. PubMed ID: 6432410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta 2 microglobulin plasma levels reflect disease activity in rheumatoid arthritis.
    Crisp AJ; Coughlan RJ; Mackintosh D; Clark B; Panayi GS
    J Rheumatol; 1983 Dec; 10(6):954-6. PubMed ID: 6420563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis].
    Bröll H; Tausch G; Teherani DK
    Wien Klin Wochenschr Suppl; 1984; 156():16. PubMed ID: 6442049
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of gold therapy with rheumatoid arthritis.
    Phillips KF
    Orthop Nurs; 1983; 2(4):31-4. PubMed ID: 6422427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.